AAIC 2017 in London

July 14, 2017 - July 20, 2017

The Alzheimer's Association International Conference will take place in our home city this summer. The conference is a global forum to advance dementia science, where international investigators, clinicians and care providers gather to share the latest study results, theories and discoveries that will help bring the world closer to breakthroughs in dementia science.

Members of our leadership team will be attending this year's conference, along with representatives from our Science, Operations and Business Development teams. If you are attending this year's conference and would like to take this opportunity to meet please contact jessica.payne@ixico.com - we'd be glad to update you on what we've been working on.

We will be presenting the following poster:
Predicting Sleep/Wake Patterns from 3-Axis Accelerometry Using Deep Learning
P3-200  |  Tuesday 18 July  |  9:30am - 4:15pm

And co-authored the following posters:
Best Combinatorial Low-Cost Markers to Predict MCI Conversion: An Emif-AD Federation Study
P4-226  |  Wednesday 19 July  |  9:30am - 4:15pm

Operationalizing Automated PET Suvr Quantification in Multi-Centre AD Clinical Trials
P4-234  |  Wednesday 19 July  |  9:30am - 4:15pm

Fully Automatic Whole Brain Longitudinal Segmentation, Validation and Operationalization
P4-258  |  Wednesday 19 July  |  9:30am - 4:15pm


AAIC 2017 IXICO Expert Symposium

Tower Bridge  |  Tuesday 18 July
With AAIC taking place in our home city, we will be holding an Expert Symposium at the iconic Tower Bridge. The theme of the evening will be Imaging and Digital Biomarkers in Alzheimer's Disease Clinical Development, and speakers include:
Introduction to the Scientific and Operational Challenges in Large Scale Amyloid Imaging in AMYPAD
Frederik Barkhof  |  AMYPAD Project Coordinator, Professor of Neuroradiology VUmc, UCL Institutes of Biomedical Engineering and Neurology
Automated Analysis of Amyloid PET in AMYPAD
Elisabetta Grecchi  |  Imaging Scientist IXICO
Regulatory Challenges with Enrichment Strategies in Alzheimer's Disease Clinical Trials
Robin Wolz  |  Director Translational Science IXICO
Digital Biomarkers of Sleep Disturbance: Path to Use in Clinical Development
Derek Hill  |  President of Regulatory Science IXICO

Spaces for the event are limited, but if you would like to attend please contact jessica.payne@ixico.com